Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tianma xingnao jiaonang
- Development stage
- Unknown
- Lead developer
- Yunnan Yongzitang Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tianma Xingnao Jiaonang is a traditional Chinese medicine (TCM) capsule formulation composed of Gastrodia elata (Tianma), Pheretima aspergillum (Dilong/earthworm), Acorus tatarinowii (Shichangpu), Polygala tenuifolia (Yuanzhi), Rehmannia glutinosa (Shudihuang), and Cistanche deserticola (Roucongrong). It is indicated for symptoms attributed to "liver and kidney deficiency" and "liver wind disturbance" in TCM, such as headache, dizziness, memory decline, insomnia, slow reactions, tinnitus, and lower back soreness. The product claims to nourish the liver and kidney, calm endogenous wind ("pinggan xifeng"), promote circulation through the meridians ("tongluo zhitong"), and relieve pain. Clinical studies suggest it may improve cognitive function in mild-to-moderate vascular dementia with these TCM syndromes[2][3][5]. Its mechanism of action is based on multi-component herbal synergy typical of TCM; pharmacological effects are thought to include neuroprotection and improvement of cerebral blood flow but specific molecular targets are not established.
- Brand names
- 天麻醒脑胶囊Tianma Xingnao Jiaonang
- Other names
- 天麻醒脑胶囊模拟剂Tianma Xingnao Jiaonang Simulation Agent
Beyond the preview
Go deeper on tianma xingnao jiaonang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tianma xingnao jiaonang.